Literature DB >> 32588155

Letter regarding the article "Immunomodulatory treatment for lymphocytic myocarditis-a systematic review and meta-analysis".

Alexey Sarapultsev1, Vasily Kashtalap2, Petr Sarapultsev3.   

Abstract

Entities:  

Year:  2021        PMID： 32588155     DOI： 10.1007/s10741-020-09999-9

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN： 1382-4147            Impact factor:   4.214


× No keyword cloud information.
  10 in total

1.  Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results.

Authors:  R Wojnicz; E Nowalany-Kozielska; C Wojciechowska; G Glanowska; P Wilczewski; T Niklewski; M Zembala; L Polonski; M M Rozek; J Wodniecki
Journal:  Circulation       Date:  2001-07-03       Impact factor: 29.690

2.  A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy.

Authors:  J E Parrillo; R E Cunnion; S E Epstein; M M Parker; A F Suffredini; M Brenner; G L Schaer; S T Palmeri; R O Cannon; D Alling
Journal:  N Engl J Med       Date:  1989-10-19       Impact factor: 91.245

Review 3.  Inflammation in myocardial disease: From myocarditis to dilated cardiomyopathy.

Authors:  Kyoko Imanaka-Yoshida
Journal:  Pathol Int       Date:  2019-11-05       Impact factor: 2.534

4.  A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators.

Authors:  J W Mason; J B O'Connell; A Herskowitz; N R Rose; B M McManus; M E Billingham; T E Moon
Journal:  N Engl J Med       Date:  1995-08-03       Impact factor: 91.245

5.  Recently diagnosed idiopathic dilated cardiomyopathy: incidence of myocarditis and efficacy of prednisone therapy.

Authors:  R D Latham; J P Mulrow; R Virmani; M Robinowitz; J M Moody
Journal:  Am Heart J       Date:  1989-04       Impact factor: 4.749

Review 6.  Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases.

Authors:  Yigal M Pinto; Perry M Elliott; Eloisa Arbustini; Yehuda Adler; Aris Anastasakis; Michael Böhm; Denis Duboc; Juan Gimeno; Pascal de Groote; Massimo Imazio; Stephane Heymans; Karin Klingel; Michel Komajda; Giuseppe Limongelli; Ales Linhart; Jens Mogensen; James Moon; Petronella G Pieper; Petar M Seferovic; Stephan Schueler; Jose L Zamorano; Alida L P Caforio; Philippe Charron
Journal:  Eur Heart J       Date:  2016-01-19       Impact factor: 29.983

7.  Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study.

Authors:  Andrea Frustaci; Matteo A Russo; Cristina Chimenti
Journal:  Eur Heart J       Date:  2009-06-25       Impact factor: 29.983

Review 8.  Treatment options in myocarditis and inflammatory cardiomyopathy : Focus on i. v. immunoglobulins.

Authors:  B Maisch; P Alter
Journal:  Herz       Date:  2018-08       Impact factor: 1.443

Review 9.  Dilated cardiomyopathy.

Authors:  Heinz-Peter Schultheiss; DeLisa Fairweather; Alida L P Caforio; Felicitas Escher; Ray E Hershberger; Steven E Lipshultz; Peter P Liu; Akira Matsumori; Andrea Mazzanti; John McMurray; Silvia G Priori
Journal:  Nat Rev Dis Primers       Date:  2019-05-09       Impact factor: 65.038

10.  Immunomodulatory treatment for lymphocytic myocarditis-a systematic review and meta-analysis.

Authors:  Max-Paul Winter; Patrick Sulzgruber; Lorenz Koller; Philipp Bartko; Georg Goliasch; Alexander Niessner
Journal:  Heart Fail Rev       Date:  2018-07       Impact factor: 4.214
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.